Top Insights
A new startup launched at the SynBioBeta conference. The company, called CybergenX, is seeking to integrate AI-powered cybergenetic technology into the synthetic biology field. By doing this, CybergenX is seeking to accelerate the potential of engineering biology in drug manufacturing.
The post This Chip Seeks to Transform Drug Manufacturing by Learning More About Intracellular Dynamics appeared first on MedCity News.
Leave a comment